Hormone-dependent tumors, such as breast cancer and endometrial cancer, are based on similar hormonal mechanisms but differ in key molecular pathways. New findings regarding hormone receptors, signaling pathways, metabolic pathways, and the tumor microenvironment are opening up new avenues for personalized therapy.
Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten
Jetzt beitreten
Already a member? Log in here
